New global surveillance tool detectsmonitors public concerns about vaccines in real time

Scientists have developed a global media surveillance system that enables them to look for, and systematically monitor, up-to-the-minute public concerns and rumors about vaccines originating from 144 countries.

The application could help public health officials respond more quickly and effectively to a loss of public confidence in vaccines before it results in vaccination refusals and , according to an Article published Online First in The Lancet Infectious Diseases.

"Recent measles outbreaks in the UK, stemming from children not-vaccinated due to fears prompted by now-discredited research over a decade ago, is one example of the long-term consequences of broken public trust in vaccines", explains lead author Heidi Larson from the London School of Hygiene & Tropical Medicine in the UK.

"The Internet has speeded up the global spread of unchecked rumours and misinformation about vaccines and can seriously undermine , leading to low rates of vaccine uptake and even disease outbreaks."

The new application builds on the capacity of HealthMap—an online surveillance resource that detects and maps early signs of disease outbreaks from electronic data sources such as news reports, blogs, social networking sites, and government announcements—to track the emergence and spread of public rumours and concerns about vaccines, vaccine programmes, and vaccine-preventable diseases from 144 countries.

Between May 2011 and April 2012, 10 380 reports were identified and categorised by type of content—positive/neutral (7171; 69%) and negative (3209; 31%)—location, and disease. The researchers also devised a typology of concerns to evaluate and prioritise reports according to their potential to disrupt vaccine uptake, to guide further investigation and intervention.

Of the negative reports, almost half were associated with vaccine impacts (eg, vaccine suspension, refusals; 24%) and belief systems (eg, religious beliefs, risk perceptions; 21%).

According to Larson, "Real-time monitoring and analysis of vaccine concerns could help governments and locally, nationally, and globally understand where they should focus their attention and resources when a concern arises, and where specific vaccines might need more tailored engagement strategies."*

Writing in a linked Comment, Natasha Crowcroft, Chief of at Public Health Ontario in Canada and Kwame Julius McKenzie from the University of Toronto in Canada say it is time to move beyond passive responses to vaccine safety events towards active preparedness, "Pre-emptive action in childhood to promote immunisation might prime the minds of future parents, health-care providers, journalists, and politicians with a positive attitude towards immunisation. The benefits and risks of immunisation could be discussed in schools as part of history, politics, science, health, and ethics courses. This approach might lead to a stronger sense of the value of immunisation for both the individual and the public."

More information: www.thelancet.com/journals/lan… (13)70108-7/abstract

add to favorites email to friend print save as pdf

Related Stories

Measles: New efforts needed to stop an old disease

Apr 25, 2013

New diseases grab headlines. The latest influenza scare – H7N9 – has prompted much speculation about the direction the virus might take. And rightly so, as vaccines to fight new viruses can take some ...

African immunization systems fall short, experts say

Mar 19, 2013

In Africa, issues of vaccine supply, financing, and sustainability require urgent attention if the Millennium Development Goals are to be achieved, according to African experts writing in this week's PLOS Medicine.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments